Atlas Trials

Evaluation of LUM001 in the Reduction of Pruritus in Alagille Syndrome

Clinical trial NCT02057692 · COMPLETED

Trial details

NCT number
NCT02057692
Sponsor
Mirum Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alagille Syndrome
Start date
2014-11-24
Primary completion
2016-11-16
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.